Mo1884 - Drug Survival of Vedolizumab-Treated Inflammatory Bowel Disease Patients in a Nationwide Observational Cohort Study: ICC Case Series

MLA

Nanne K. H. de Boer, et al. “Mo1884 - Drug Survival of Vedolizumab-Treated Inflammatory Bowel Disease Patients in a Nationwide Observational Cohort Study: ICC Case Series.” Gastroenterology, vol. 154, May 2018, p. S-838. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b9a7be733377d1524fe1948d86345787&authtype=sso&custid=ns315887.

APA

Nanne K. H. de Boer, Gerard Dijkstra, Annemarie C. de Vries, Vince B. C. Biemans, Andrea Van Der Meulen, Christien J. van der Woude, Jeoffrey J L Haans, Bas Oldenburg, Marie J. Pierik, Frank Hoentjen, & Cyriel Y. Ponsioen. (2018). Mo1884 - Drug Survival of Vedolizumab-Treated Inflammatory Bowel Disease Patients in a Nationwide Observational Cohort Study: ICC Case Series. Gastroenterology, 154, S-838.

Chicago

Nanne K. H. de Boer, Gerard Dijkstra, Annemarie C. de Vries, Vince B. C. Biemans, Andrea Van Der Meulen, Christien J. van der Woude, Jeoffrey J L Haans, et al. 2018. “Mo1884 - Drug Survival of Vedolizumab-Treated Inflammatory Bowel Disease Patients in a Nationwide Observational Cohort Study: ICC Case Series.” Gastroenterology 154 (May): S-838. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........b9a7be733377d1524fe1948d86345787&authtype=sso&custid=ns315887.